X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs ELDER PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. ELDER PHARMA FDC LTD./
ELDER PHARMA
 
P/E (TTM) x 22.2 -0.2 - View Chart
P/BV x 5.0 0.1 4,949.5% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 FDC LTD.   ELDER PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
ELDER PHARMA
Jun-14
FDC LTD./
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs144380 37.8%   
Low Rs79188 42.0%   
Sales per share (Unadj.) Rs47.6491.2 9.7%  
Earnings per share (Unadj.) Rs7.6-3.2 -239.2%  
Cash flow per share (Unadj.) Rs9.014.4 62.5%  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.5376.5 12.6%  
Shares outstanding (eoy) m177.8320.54 865.8%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.30.6 404.5%   
Avg P/E ratio x14.6-89.3 -16.4%  
P/CF ratio (eoy) x12.319.7 62.6%  
Price / Book Value ratio x2.30.8 310.3%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,7845,833 339.1%   
No. of employees `000NANA-   
Total wages/salary Rs m1,2212,179 56.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m8,45910,089 83.8%  
Other income Rs m394257 153.4%   
Total revenues Rs m8,85210,346 85.6%   
Gross profit Rs m2,070-792 -261.4%  
Depreciation Rs m249361 68.9%   
Interest Rs m312,756 1.1%   
Profit before tax Rs m2,184-3,653 -59.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m606125 483.9%   
Profit after tax Rs m1,353-65 -2,070.6%  
Gross profit margin %24.5-7.8 -311.8%  
Effective tax rate %27.7-3.4 -809.4%   
Net profit margin %16.0-0.6 -2,469.8%  
BALANCE SHEET DATA
Current assets Rs m4,3559,240 47.1%   
Current liabilities Rs m1,7929,998 17.9%   
Net working cap to sales %30.3-7.5 -403.5%  
Current ratio x2.40.9 263.0%  
Inventory Days Days4446 96.0%  
Debtors Days Days2560 41.2%  
Net fixed assets Rs m3,02510,124 29.9%   
Share capital Rs m179206 86.8%   
"Free" reserves Rs m8,2435,582 147.7%   
Net worth Rs m8,4537,734 109.3%   
Long term debt Rs m114,889 0.2%   
Total assets Rs m10,55722,882 46.1%  
Interest coverage x71.4-0.3 -21,954.5%   
Debt to equity ratio x00.6 0.2%  
Sales to assets ratio x0.80.4 181.7%   
Return on assets %13.111.8 111.5%  
Return on equity %16.0-0.8 -1,894.4%  
Return on capital %23.522.3 105.4%  
Exports to sales %13.33.0 437.9%   
Imports to sales %3.30.4 782.6%   
Exports (fob) Rs m1,126307 367.2%   
Imports (cif) Rs m28343 656.1%   
Fx inflow Rs m1,146307 373.8%   
Fx outflow Rs m355125 283.6%   
Net fx Rs m791181 436.2%   
CASH FLOW
From Operations Rs m1,48511,754 12.6%  
From Investments Rs m-620-561 110.5%  
From Financial Activity Rs m-753-6,762 11.1%  
Net Cashflow Rs m1134,432 2.5%  

Share Holding

Indian Promoters % 68.9 39.6 174.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 7.5 62.7%  
FIIs % 7.5 16.8 44.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 36.1 52.6%  
Shareholders   23,730 16,479 144.0%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   SHASUN PHARMA  DR. REDDYS LAB  GSK PHARMA  UNICHEM LAB  MERCK LTD  

Compare FDC LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY18); Net Profit Down 35.8% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, FDC LTD. has posted a net profit of Rs 315 m (down 35.8% YoY). Sales on the other hand came in at Rs 3 bn (up 5.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Sep 21, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - SUVEN LIFE COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS